BlackRock
COCH icon

BlackRock’s Envoy Medical COCH Stock Holding History

BlackRock’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.21K Sell
5,309
-42,205
-89% -$28.7K ﹤0.01% 5504
2026
Q1 		$31.6K Buy
47,514
+7,609
+19% +$5.19K ﹤0.01% 5225
2025
Q4 		$26.4K Buy
39,905
+16,486
+70% +$13.1K ﹤0.01% 5169
2025
Q3 		$18.2K Sell
23,419
-159
-0.7% -$216 ﹤0.01% 5158
2025
Q2 		$33.5K Buy
23,578
+8,007
+51% +$11.7K ﹤0.01% 5062
2025
Q1 		$20.2K Sell
15,571
-282
-2% -$413 ﹤0.01% 5090
2024
Q4 		$22.7K Buy
15,853
+94
+0.6% +$214 ﹤0.01% 5086
2024
Q3 		$51.2K Buy
15,759
+5,461
+53% +$14.9K ﹤0.01% 4812
2024
Q2 		$24.3K Buy
10,298
+9,469
+1,142% +$35.2K ﹤0.01% 4985
2024
Q1 		$3.25K Buy
+829
New +$2.43K ﹤0.01% 5164

Other funds holding COCH

DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AFS
AFG Fiduciary Services Hingham, Massachusetts $128M AUM 24.3% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
BA
Ballew Advisors Jackson, Mississippi $194M AUM 20.37% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
ACA
American Capital Advisory Ketchum, Idaho $275M AUM 22.21% 1-Year Est. Return

BlackRock's COCH Position: Q2 2026 in Review

BlackRock reduced its Envoy Medical (COCH) stake by 89% in Q2 2026, selling an estimated $28.7K and leaving 5,309 shares worth $4.21K. The position accounts for ﹤0.01% of the portfolio, ranked #5504.

BlackRock first reported a position in COCH in Q1 2024 and has held it in 10 quarters since. The position peaked at $51.2K in Q3 2024. 10 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • BlackRock held 5,309 shares of Envoy Medical worth $4.21K as of Q2 2026.
  • BlackRock sold 42,205 Envoy Medical shares in Q2 2026, an estimated $28.7K.
  • Envoy Medical made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5504 holding.
  • BlackRock first reported a position in Envoy Medical in Q1 2024 and has held it in 10 quarters since.
  • BlackRock's Envoy Medical position peaked at $51.2K in Q3 2024.
  • 10 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.